Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Temperature dependence of the photoluminescence in poly(ethylene terephthalate) films

Autor: Teyssèdre, G ^*, Menegotto, J, Laurent, C

Publikováno v: In Polymer 2001 42(19):8207-8216

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance.

Autor: Murithi JM; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Pascal C; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bath J; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Boulenc X; Sanofi Pasteur, Marcy L'Etoile, France., Gnädig NF; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Pasaje CFA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Rubiano K; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Yeo T; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Mok S; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Klieber S; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Desert P; Sanofi Pasteur, Marcy L'Etoile, France., Jiménez-Díaz MB; The Art of Discovery, Bizkaia, Basque Country, Spain., Marfurt J; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia., Rouillier M; Medicines for Malaria Venture, Geneva, Switzerland., Cherkaoui-Rbati MH; Medicines for Malaria Venture, Geneva, Switzerland., Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland., Wittlin S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; Universität Basel, Basel, Switzerland., Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Price RN; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Wirjanata G; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia., Noviyanti R; Eijkman Institute for Molecular Biology, Jakarta, Indonesia., Tumwebaze P; Infectious Diseases Research Collaboration, Kampala, Uganda., Cooper RA; Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA, USA., Rosenthal PJ; Department of Medicine, University of California, San Francisco, CA, USA., Sanz LM; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain., Gamo FJ; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain., Joseph J; Syngene International Ltd., Bangalore, India., Singh S; Syngene International Ltd., Bangalore, India., Bashyam S; Syngene International Ltd., Bangalore, India., Augereau JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Giraud E; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bozec T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Vermat T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Tuffal G; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Guillon JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Menegotto J; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Sallé L; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Louit G; Sanofi, Vitry-sur-Seine, France., Cabanis MJ; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Nicolas MF; Sanofi, Vitry-sur-Seine, France., Doubovetzky M; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Merino R; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bessila N; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Angulo-Barturen I; The Art of Discovery, Bizkaia, Basque Country, Spain., Baud D; Medicines for Malaria Venture, Geneva, Switzerland., Bebrevska L; Medicines for Malaria Venture, Geneva, Switzerland., Escudié F; Medicines for Malaria Venture, Geneva, Switzerland., Niles JC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Blasco B; Medicines for Malaria Venture, Geneva, Switzerland., Campbell S; Medicines for Malaria Venture, Geneva, Switzerland., Courtemanche G; Bioaster, Paris, France., Fraisse L; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Pellet A; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. df2260@cumc.columbia.edu leroyd@mmv.org.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Leroy D; Medicines for Malaria Venture, Geneva, Switzerland. df2260@cumc.columbia.edu leroyd@mmv.org.

Publikováno v: Science translational medicine [Sci Transl Med] 2021 Jul 21; Vol. 13 (603).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification and optimization of a new series of anti-tubercular quinazolinones.

Autor: Couturier C; Sanofi R&D, TSU Infectious Disease, 1541, Avenue Marcel Merieux, 69280 Marcy l'Etoile, France. Electronic address: cedric.couturier@sanofi.com., Lair C; Sanofi R&D, TSU Infectious Disease, 1541, Avenue Marcel Merieux, 69280 Marcy l'Etoile, France., Pellet A; Sanofi R&D, TSU Infectious Disease, 1541, Avenue Marcel Merieux, 69280 Marcy l'Etoile, France., Upton A; Global Alliance for TB Drug Development, New York, NY 10005, United States., Kaneko T; Global Alliance for TB Drug Development, New York, NY 10005, United States., Perron C; Sanofi R&D, Lead Generation and Candidate Realization, 195, route d'Espagne BP 13669, 31036 Toulouse Cedex 1, France., Cogo E; Sanofi R&D, Lead Generation and Candidate Realization, 195, route d'Espagne BP 13669, 31036 Toulouse Cedex 1, France., Menegotto J; Sanofi R&D, Lead Generation and Candidate Realization, 195, route d'Espagne BP 13669, 31036 Toulouse Cedex 1, France., Bauer A; Sanofi Deutschland GmbH, Lead Generation and Candidate Realization, Industriepark Hoechst, 65926 Frankfurt am Main, Germany., Scheiper B; Sanofi Deutschland GmbH, Lead Generation and Candidate Realization, Industriepark Hoechst, 65926 Frankfurt am Main, Germany., Lagrange S; Sanofi R&D, TSU Infectious Disease, 1541, Avenue Marcel Merieux, 69280 Marcy l'Etoile, France., Bacqué E; Sanofi R&D, TSU Infectious Disease, 1541, Avenue Marcel Merieux, 69280 Marcy l'Etoile, France.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Nov 01; Vol. 26 (21), pp. 5290-5299. Date of Electronic Publication: 2016 Sep 16.